KKR & Co. Inc. (NYSE:KKR – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Thursday, October 24th. Analysts expect the company to announce earnings of $1.05 per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.
KKR & Co. Inc. (NYSE:KKR – Get Free Report) last released its quarterly earnings results on Wednesday, July 31st. The asset manager reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.20. KKR & Co. Inc. had a return on equity of 5.05% and a net margin of 17.99%. The firm had revenue of $4.17 billion for the quarter, compared to the consensus estimate of $1.07 billion. During the same quarter last year, the business posted $0.58 EPS. On average, analysts expect KKR & Co. Inc. to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
KKR & Co. Inc. Price Performance
Shares of NYSE KKR opened at $140.17 on Wednesday. The stock has a market cap of $124.39 billion, a P/E ratio of 31.43, a P/E/G ratio of 1.14 and a beta of 1.62. KKR & Co. Inc. has a twelve month low of $53.72 and a twelve month high of $141.68. The stock has a 50 day moving average of $127.21 and a two-hundred day moving average of $113.35. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.86.
KKR & Co. Inc. Announces Dividend
Insider Transactions at KKR & Co. Inc.
In related news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the completion of the transaction, the insider now directly owns 25,260,971 shares of the company’s stock, valued at $650,470,003.25. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, major shareholder Kkr Group Partnership L.P. sold 2,554,644 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $18.85, for a total transaction of $48,155,039.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of KKR & Co. Inc. stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the transaction, the insider now owns 25,260,971 shares of the company’s stock, valued at $650,470,003.25. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 39.34% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on KKR shares. TD Cowen upped their target price on shares of KKR & Co. Inc. from $145.00 to $154.00 and gave the company a “buy” rating in a report on Thursday, August 1st. Barclays increased their price objective on KKR & Co. Inc. from $146.00 to $149.00 and gave the stock an “overweight” rating in a research report on Monday, October 7th. Hsbc Global Res upgraded KKR & Co. Inc. to a “strong-buy” rating in a research note on Wednesday, September 18th. Oppenheimer boosted their price objective on shares of KKR & Co. Inc. from $128.00 to $148.00 and gave the company an “outperform” rating in a research note on Wednesday, October 16th. Finally, Redburn Atlantic initiated coverage on shares of KKR & Co. Inc. in a research note on Tuesday, August 27th. They issued a “buy” rating and a $153.00 target price for the company. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, KKR & Co. Inc. currently has a consensus rating of “Moderate Buy” and an average target price of $144.43.
View Our Latest Stock Report on KKR
KKR & Co. Inc. Company Profile
KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.
Featured Articles
- Five stocks we like better than KKR & Co. Inc.
- How to Plot Fibonacci Price Inflection Levels
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- About the Markup Calculator
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for KKR & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KKR & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.